115 related articles for article (PubMed ID: 24732790)
1. Discovery of small molecular (D)-leucinamides as potent, Notch-sparing γ-secretase modulators.
Liao YF; Tang YC; Chang MY; Wang BJ; Hu MK
Eur J Med Chem; 2014 May; 79():143-51. PubMed ID: 24732790
[TBL] [Abstract][Full Text] [Related]
2. Membrane anchoring γ-secretase modulators with terpene-derived moieties.
Naumann EC; Göring S; Ogorek I; Weggen S; Schmidt B
Bioorg Med Chem Lett; 2013 Jul; 23(13):3852-6. PubMed ID: 23707256
[TBL] [Abstract][Full Text] [Related]
3. Small molecules that inhibit Notch signaling.
De Kloe GE; De Strooper B
Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
[TBL] [Abstract][Full Text] [Related]
4. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
[TBL] [Abstract][Full Text] [Related]
6. Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.
Rivkin A; Ahearn SP; Chichetti SM; Kim YR; Li C; Rosenau A; Kattar SD; Jung J; Shah S; Hughes BL; Crispino JL; Middleton RE; Szewczak AA; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2010 Feb; 20(3):1269-71. PubMed ID: 20022243
[TBL] [Abstract][Full Text] [Related]
7. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
8. Purine derivatives as potent gamma-secretase modulators.
Rivkin A; Ahearn SP; Chichetti SM; Hamblett CL; Garcia Y; Martinez M; Hubbs JL; Reutershan MH; Daniels MH; Siliphaivanh P; Otte KM; Li C; Rosenau A; Surdi LM; Jung J; Hughes BL; Crispino JL; Nikov GN; Middleton RE; Moxham CM; Szewczak AA; Shah S; Moy LY; Kenific CM; Tanga F; Cruz JC; Andrade P; Angagaw MH; Shomer NH; Miller T; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2010 Apr; 20(7):2279-82. PubMed ID: 20207146
[TBL] [Abstract][Full Text] [Related]
9. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
[TBL] [Abstract][Full Text] [Related]
10. γ-Secretase as a target for Alzheimer's disease.
Wolfe MS
Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
[TBL] [Abstract][Full Text] [Related]
11. Difluorophenylglycinols as new modulators of proteolytic processing of amyloid precursor proteins.
Chen CY; Liao YF; Chang MY; Hu MK
Arch Pharm (Weinheim); 2014 Mar; 347(3):161-73. PubMed ID: 24339192
[TBL] [Abstract][Full Text] [Related]
12. SAR studies of acidic dual γ-secretase/PPARγ modulators.
Hieke M; Ness J; Steri R; Greiner C; Werz O; Schubert-Zsilavecz M; Weggen S; Zettl H
Bioorg Med Chem; 2011 Sep; 19(18):5372-82. PubMed ID: 21873070
[TBL] [Abstract][Full Text] [Related]
13. (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor.
Cole DC; Stock JR; Kreft AF; Antane M; Aschmies SH; Atchison KP; Casebier DS; Comery TA; Diamantidis G; Ellingboe JW; Harrison BL; Hu Y; Jin M; Kubrak DM; Lu P; Mann CW; Martone RL; Moore WJ; Oganesian A; Riddell DR; Sonnenberg-Reines J; Sun SC; Wagner E; Wang Z; Woller KR; Xu Z; Zhou H; Jacobsen JS
Bioorg Med Chem Lett; 2009 Feb; 19(3):926-9. PubMed ID: 19097890
[TBL] [Abstract][Full Text] [Related]
14. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of γ-secretase inhibition and modulation by small molecule drugs.
Yang G; Zhou R; Guo X; Yan C; Lei J; Shi Y
Cell; 2021 Jan; 184(2):521-533.e14. PubMed ID: 33373587
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Albright CF; Dockens RC; Meredith JE; Olson RE; Slemmon R; Lentz KA; Wang JS; Denton RR; Pilcher G; Rhyne PW; Raybon JJ; Barten DM; Burton C; Toyn JH; Sankaranarayanan S; Polson C; Guss V; White R; Simutis F; Sanderson T; Gillman KW; Starrett JE; Bronson J; Sverdlov O; Huang SP; Castaneda L; Feldman H; Coric V; Zaczek R; Macor JE; Houston J; Berman RM; Tong G
J Pharmacol Exp Ther; 2013 Mar; 344(3):686-95. PubMed ID: 23275065
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells.
Rennhack A; Jumpertz T; Ness J; Baches S; Pietrzik CU; Weggen S; Bulic B
Bioorg Med Chem; 2012 Nov; 20(21):6523-32. PubMed ID: 23000293
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
20. Important functional role of residue x of the presenilin GxGD protease active site motif for APP substrate cleavage specificity and substrate selectivity of γ-secretase.
Kretner B; Fukumori A; Kuhn PH; Pérez-Revuelta BI; Lichtenthaler SF; Haass C; Steiner H
J Neurochem; 2013 Apr; 125(1):144-56. PubMed ID: 23237322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
